Janux Therapeutics, Inc. (JANX)
NASDAQ: JANX · Real-Time Price · USD
13.61
-0.19 (-1.38%)
At close: Feb 27, 2026, 4:00 PM EST
13.88
+0.27 (1.98%)
After-hours: Feb 27, 2026, 7:36 PM EST

Janux Therapeutics Stock Forecast

Stock Price Forecast

The 11 analysts that cover Janux Therapeutics stock have a consensus rating of "Buy" and an average price target of $52.45, which forecasts a 285.38% increase in the stock price over the next year. The lowest target is $12 and the highest is $100.

Price Target: $52.45 (+285.38%)
Analyst Consensus: Buy
TargetLowAverageMedianHigh
Price$12$52.45$45$100
Change-11.83%+285.38%+230.64%+634.75%

Analyst Ratings

The average analyst rating for Janux Therapeutics stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

RatingSep '25Oct '25Nov '25Dec '25Jan '26Feb '26
Strong Buy554655
Buy555444
Hold112233
Sell000000
Strong Sell000000
Total111111121212

Latest Forecasts

AnalystFirmRatingRatingActionPrice TargetUpsideDate
Cantor Fitzgerald
Cantor Fitzgerald
Buy
Maintains
$150$100
BuyMaintains$150$100+634.75%Feb 27, 2026
Guggenheim
Guggenheim
Strong Buy
Maintains
$72$68
Strong BuyMaintains$72$68+399.63%Feb 27, 2026
Clear Street
Clear Street
Hold
Downgrades
$32$12
HoldDowngrades$32$12-11.83%Jan 20, 2026
Piper Sandler
Piper Sandler
Buy
Maintains
$42$30
BuyMaintains$42$30+120.43%Jan 16, 2026
Barclays
Barclays
Buy
Maintains
$48$29
BuyMaintains$48$29+113.08%Dec 17, 2025
More Analyst Ratings

Financial Forecast

Revenue This Year
1.43M
from 10.00M
Decreased by -85.66%
Revenue Next Year
4.81M
from 1.43M
Increased by 235.70%
EPS This Year
-2.97
from -1.83
EPS Next Year
-3.81
from -2.97
Fiscal YearFY 2021FY 2022FY 2023FY 2024FY 2025FY 2026FY 2027
Period EndingDec 31, 2021Dec 31, 2022Dec 31, 2023Dec 31, 2024Dec 31, 2025Dec 31, 2026Dec 31, 2027
Revenue
3.64M8.61M8.08M10.59M10.00M1.43M4.81M
Revenue Growth
-136.79%-6.14%30.99%-5.55%-85.66%235.70%
EPS
-1.39-1.52-1.32-1.28-1.83-2.97-3.81
EPS Growth
-------
Forward PE
-------
No. Analysts
-----1916
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue20262027202820292030
High7.9M35.3M
Avg1.4M4.8M
Lown/an/a

Revenue Growth

Revenue Growth20262027202820292030
High
-21.3%
2,362.8%
Avg
-85.7%
235.7%
Low--

EPS Forecast

EPS20262027202820292030
High-2.46-2.89
Avg-2.97-3.81
Low-4.51-5.84

EPS Growth

EPS Growth20262027202820292030
High--
Avg--
Low--
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.